Matthew Killeen

Chief Tech/Sci/R&D Officer at RENOVACOR, INC.

44 year

Health Technology

Consumer Services

Retail Trade

Profile

Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd. Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.

Matthew Killeen active positions

Companies	Position	Start
RENOVACOR, INC.	Chief Tech/Sci/R&D Officer	2021-08-31
CREAGRI, Inc. CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols	Corporate Officer/Principal	2011-05-11
Sudden Cardiac Arrest Foundation Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US.	Director/Board Member	-

All active positions of Matthew Killeen

Former positions of Matthew Killeen

Companies	Position	End
BIOMARIN PHARMACEUTICAL INC.	Chief Tech/Sci/R&D Officer	-
Eli Lilly & Co. Ltd. Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions	Corporate Officer/Principal	-

See the detail of Matthew Killeen's experience

Training of Matthew Killeen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Killeen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Leeds University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eli Lilly & Co. Ltd. Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions	Health Technology
CREAGRI, Inc. CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols	Retail Trade
Renovacor, Inc. Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases	Health Technology
Sudden Cardiac Arrest Foundation Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US.	Commercial Services